Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
123.07
-0.22 (-0.18%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sarepta Therapeutics Analyst Ratings
Total Analysts
20
Consensus Rating
Strong Buy
Price Target
$183.65
Upside
+49.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $182 | Buy | Reiterates | $182 | +47.88% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $165 | Strong Buy | Initiates | $165 | +34.07% | Oct 21, 2024 |
| Needham | Needham | Strong Buy Reiterates $205 | Strong Buy | Reiterates | $205 | +66.57% | Oct 14, 2024 |
| Raymond James | Raymond James | Buy Initiates $150 | Buy | Initiates | $150 | +21.88% | Oct 10, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $181 → $182 | Buy | Maintains | $181 → $182 | +47.88% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $152 | Hold | Reiterates | $152 | +23.51% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $181 | Buy | Reiterates | $181 | +47.07% | Sep 19, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $181 | Buy | Reiterates | $181 | +47.07% | Sep 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $181 | Buy | Reiterates | $181 | +47.07% | Aug 15, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $182 → $181 | Buy | Maintains | $182 → $181 | +47.07% | Aug 8, 2024 |
| Citigroup | Citigroup | Hold Maintains $176 → $160 | Hold | Maintains | $176 → $160 | +30.01% | Aug 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $167 → $152 | Hold | Maintains | $167 → $152 | +23.51% | Aug 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $205 → $200 | Buy | Maintains | $205 → $200 | +62.51% | Aug 8, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $185 → $179 | Hold → Buy | Upgrades | $185 → $179 | +45.45% | Aug 8, 2024 |
| Barclays | Barclays | Buy Maintains $226 → $203 | Buy | Maintains | $226 → $203 | +64.95% | Aug 8, 2024 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $182 | Hold → Buy | Upgrades | $182 | +47.88% | Jul 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.